2 These challenges alleged that the advertisers claims regarding the health benefits, safety and effectiveness of the compounded products were false, misleading and/or unsubstantiated
To assess the association of semaglutide with incident CUD, the study population included 587,849 patients with T2D who had active medical encounters for T2D during 12/20175/2021, were for the first time prescribed semaglutide (Ozempic) or non-GLP1-1RA anti-diabetes medications (new-user design) during 12/20175/2021(index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
2025 Drug Trend Report
GSBR-1290 targets the "weekly oral" quadrant, an unoccupied niche with no approved products
Furthermore, glutathione has been shown to help reduce the production of melanin, which can help improve skin tone and reduce the appearance of dark spots and hyperpigmentation
Oral semaglutide, which provides comparable benefits in HbA1c reduction and weight loss to injectable GLP-1 receptor agonists, is a valuable non-injectable alternative to consider before progressing to injectables